THROMBOLOGIC ApS: Financial statements 2012
CVR: 32299814
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
THROMBOLOGIC ApS (CVR 32299814) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -2,904,980 and a net result of DKK -2,792,212. Equity in the 2012 report amounted to DKK -1,331,545.
- Gross Profit
- DKK -2,904,980
- Profit/Loss
- DKK -2,792,212
- Equity
- DKK -1,331,545
- Total Assets
- DKK 4,237,007
Keep an eye on THROMBOLOGIC ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of November 20, 2012, EY Danmark A/S has been appointed auditor of THROMBOLOGIC ApS.
As of November 20, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of THROMBOLOGIC ApS.
As of January 1, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of THROMBOLOGIC ApS.
As of January 1, 2012, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of THROMBOLOGIC ApS.
About THROMBOLOGIC ApS
THROMBOLOGIC ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2009 and dissolved in 2014. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2013). In 2012, the company reported a gross profit of DKK -2,904,980 and a net result of DKK -2,792,212. Equity in the 2012 report amounted to DKK -1,331,545.